Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

A new report makes the economic and environmental case for the U.S. investing billions of dollars to build what is known as the bioeconomy.

Why it matters: Transitioning to bio-based food, fuel, materials and more could sharply reduce carbon emissions and provide a foundation for a more sustainable manufacturing economy.

  • But while the U.S. is a world leader in biotech, it lags behind on the infrastructure and support needed to scale those innovations, the report finds.

By the numbers: A preliminary report from the Schmidt Futures Bioeconomy Task Force, which Axios was given early access to, calculates that the biology-based economy was already generating $960 billion in economic activity in 2016 — 5% of U.S. GDP.

  • But should the U.S. invest billions in bioeconomy research and manufacturing, it has the potential to create more than a million new jobs, keep $260 billion in economic activity from going overseas, and reduce annual CO2 emissions by 450 million tons.
  • "We believe that interdisciplinarity is the key to unlocking the next generation of scientific breakthroughs and because of this, we invest in high-risk, high-reward research like the bioeconomy which has the potential to improve the lives of everyone across the globe," says Eric Braverman, CEO of Schmidt Futures, a philanthropic initiative founded by Eric and Wendy Schmidt that focuses on supporting people solving hard problems in science and society.

Between the lines: While much of the attention on biotech tends to focus on medicine or fuel, some of the most promising applications involve using biological engineering to make fabrics, replace materials like plastics currently made with petrochemicals, and make farming more sustainable.

The catch: "What's missing is the next step, the lack of basic research into understanding the science of manufacturing and the science of biomanufacturing," says Andrea Hodgson, a fellow at Schmidt Futures and co-leader of its bioeconomy program.

  • Most bioscience research in the U.S. is curiosity-driven, rather than application driven, the report finds, leaving the country at risk of falling behind the E.U. and China in actually translating biotechnology into economic value.
  • "We don't want to go the way of the semiconductor industry," where innovation at home doesn't translate to domestic industry, says Mary Maxon, a senior fellow at Schmidt Futures who also co-leads its bioeconomy program.

What to watch: The report recommends that the government invest $600 million over five years in a Bioproduction Science Initiative overseen by the National Science Foundation, as well as another $1.2 billion in bioproduction infrastructure and public-private partnerships to scale development.

The bottom line: "The investments are needed to solve today's problems and set the course for a truly circular economy in the future, ensuring the U.S. keeps the competitive edge on biotech," says Maxon.

Editor's note: This story has been updated to describe Schmidt Futures' focus on supporting people working on social and science problems.

Go deeper

Philadelphia City Commissioner Al Schmidt to head good government group

Philadelphia City Commissioners Al Schmidt, right, and Lisa Deeley speak to the media as election workers process ballots for the 2020 general election. Photo: Matt Slocum/AP

Philadelphia City Commissioner Al Schimdt is forgoing a fourth-term run to lead local government watchdog group Committee of Seventy next year.

Driving the news: The nonprofit named Schmidt as its new CEO, starting Jan. 3, 2022, according to a statement released Tuesday.

  • "I look forward to stepping into this new role and building on the organization's 117-year history of delivering democracy," Schmidt said.
Kate Marino, author of Markets
46 mins ago - Economy & Business

Omicron outbreaks were bad for business in January

Data: New York Federal Reserve Bank; Chart: Axios Visuals

Emerging anecdotal evidence shows just how hard the recent rise in COVID-19 cases hit businesses in early January — but that hasn't hurt some business leaders’ longer-term views on their companies' prospects.

Why it matters: Increasingly, the economic recovery has come in fits and starts that move in tandem with new peaks in cases. Look no further than the thousands of cancelled flights and shuttered Broadway theaters in the wake of the Omicron variant's spread over the last few months.

Tina Reed, author of Vitals
1 hour ago - Health

The shifting definition of fully vaccinated

Illustration: Sarah Grillo/Axios

The definition of what it means to be "fully vaccinated" is evolving even as the CDC has remained careful not to officially change it.

Why it matters: CDC officials have been balancing the job of convincing Americans who've already gotten two doses of the importance of boosters with getting many Americans who still need their first doses to get their shots at all.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!